Huette, Pierre https://orcid.org/0000-0003-1563-4869
Moussa, Mouhamed
Diouf, Momar
Lefebvre, Thomas
Bayart, Guillaume
Guilbart, Mathieu
Viart, Christophe
Haye, Guillaume
Bar, Stéphane
Caus, Thierry
Soriot-Thomas, Sandrine
Boddaert, Sophie
Alshatri, Hamza Yahia
Tarpin, Paul
Fumery, Ottilie
Beyls, Christophe
Dupont, Hervé
Mahjoub, Yazine
Besnier, Emmanuel
Abou-Arab, Osama
Funding for this research was provided by:
Direction Générale de l’offre de Soins (API21-01)
Article History
Received: 14 May 2024
Accepted: 8 July 2024
First Online: 16 September 2024
Declarations
:
: The protocol was approved by the Ethics Committee (Comité de Protection des Personnes Nord-Ouest III, 80054 Amiens, France, registration number ID RDB: 2023–506299-28–00) on the 12th of March 2024 and by the ANSM (Agence Nationale de Sécurité du Médicament). Written informed consent will be obtained from all participants or next of kin. Registered on ClinicalTrials.gov on 24th April of 2024 (identifier: NCT06381063).SPIRIT checklist for <i>Trials</i> was used to draft this manuscript.
: Not applicable. No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. The participant information materials and informed consent form are available from the corresponding author on request.
: The authors declare that they have no competing interests.